Citation: Mj. Loza et B. Perussia, Final steps of natural killer cell maturation: a model for type 1 type 2 differentiation?, NAT IMMUNOL, 2(10), 2001, pp. 917-924
Authors:
Metelitsa, LS
Naidenko, OV
Kant, A
Wu, HW
Loza, MJ
Perussia, B
Kronenberg, M
Seeger, RC
Citation: Ls. Metelitsa et al., Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activateNK cells, J IMMUNOL, 167(6), 2001, pp. 3114-3122
Authors:
Powzaniuk, MA
Trotta, R
Loza, MJ
Harth, A
Iozzo, RV
Eisenlohr, LC
Perussia, B
Calabretta, B
Citation: Ma. Powzaniuk et al., B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells, J IMMUNOL, 167(1), 2001, pp. 242-249
Authors:
Trotta, R
Fettucciari, K
Azzoni, L
Abebe, B
Puorro, KA
Eisenlohr, LC
Perussia, B
Citation: R. Trotta et al., Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity, J IMMUNOL, 165(4), 2000, pp. 1782-1789
Citation: B. Perussia et Mj. Loza, Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cells, METH MOL B, 121, 2000, pp. 179-192
Authors:
Zamai, L
Ahmad, M
Bennett, IM
Azzoni, L
Alnemri, ES
Perussia, B
Citation: L. Zamai et al., Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells, J EXP MED, 188(12), 1998, pp. 2375-2380